BellRing Brands, Inc. (BRBR) - 10-K Summary
Business Context and Reporting Period
Company: BellRing Brands, Inc.
Filing Type: Form 10-K (Annual Report)
Reporting Period: Fiscal year ended September 30, 2025
Business Overview: BellRing is a leader in the global convenient nutrition category, primarily marketing ready-to-drink (RTD) protein shakes and powders under the Premier Protein (85.9% of sales) and Dymatize (12.1% of sales) brands. The company operates as a single segment and relies heavily on third-party contract manufacturers for production.
Key Financial Metrics
| Metric (in millions) | Fiscal 2025 | Fiscal 2024 | Change |
|---|---|---|---|
| Net Sales | $2,316.6 | $1,996.2 | +16% |
| Operating Profit | $357.4 | $387.7 | -8% |
| Net Earnings | $216.2 | $246.5 | -12% |
| Diluted EPS | $1.68 | $1.86 | -10% |
| Operating Cash Flow | $260.6 | $199.6 | +31% |
| Total Debt (Principal) | $1,090.0 | $840.0 | +30% |
| Cash & Equivalents | $71.8 | $70.8 | +1% |
Margins: Gross margin was approximately 33.3% in 2025 ($770.4M / $2,316.6M). Operating margin declined to 15.4% from 19.4% in the prior year.
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 16% driven by a 17% increase in Premier Protein sales (15% volume growth) and a 13% increase in Dymatize sales (23% volume growth, primarily international).
- Profitability Decline: Despite revenue growth, Operating Profit and Net Earnings declined. This was primarily due to a $69.0 million provision for legal matters related to Joint Juice litigation and higher net product costs ($72.1M increase) driven by raw material and manufacturing inflation.
- Debt Structure: Total debt increased significantly as the company borrowed $700.0 million under its Revolving Credit Facility (net of $450.0M repayments). The company also amended its credit agreement to increase facility capacity to $500.0 million and extend the maturity date.
- Share Repurchases: The company repurchased 9.0 million shares at a total cost of $476.6 million, compared to 2.6 million shares for $148.0 million in the prior year.
Guidance, Outlook, and Risks
Management Commentary: Management expects inflationary pressures on input costs (raw materials, packaging, manufacturing) to continue into fiscal 2026. They anticipate potential supply chain challenges and cost volatility due to announced tariffs and global trade policy changes.
Key Risks & Contingencies:
- Legal Liability: A significant portion of the profit decline was due to the Joint Juice litigation. The company has accrued $90.0 million for these matters. Settlements were reached in principle in late 2025 for the New York and Multistate cases, with total payments expected to be approximately $90.0 million ($19.2M + $70.8M).
- Supply Chain Concentration: The company relies on third-party manufacturers for nearly all production. One manufacturer provides approximately 46.3% of Premier Protein RTD shake supply, and a single facility accounts for 28.0% of that supply.
- Customer Concentration: Three customers (Walmart/Sam's Club, Costco, and Amazon) accounted for approximately 74.0% of net sales in fiscal 2025.
- Debt Covenants: The company must maintain a total net leverage ratio not exceeding 6.00:1.00. Management confirmed compliance as of September 30, 2025.
Investor Verification Checklist
- Legal Settlement Finality: Verify the final approval status and exact payout timing of the Joint Juice litigation settlements (New York and Multistate) to confirm the $90.0M accrual is sufficient.
- Input Cost Inflation: Monitor raw material costs (whey/milk protein) and packaging prices to assess the ability to pass costs to consumers without volume erosion.
- Debt Servicing: Review the impact of the increased Revolving Credit Facility utilization ($250M outstanding) on interest expense and future liquidity, given the 6.14% variable rate.
- Customer Concentration: Assess the risk of margin compression or volume loss given that 74% of sales depend on three major retailers.
- Share Repurchase Authorization: Note the new $400 million repurchase authorization approved in September 2025 and the remaining balance of approximately $316.5 million.